Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vilas Nasare

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Vaccine|May 6, 2008
Prospects and prejudices of human papillomavirus vaccines in IndiaBhudev C Das, Showket Hussain, Vilas Nasare, et al.
Medical Oncology (Northwood, London, England)|December 14, 2024
Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeuticsSushmita Ghosh, Arpana Sharma, R Suresh Kumar, et al.
The Indian Journal of Medical Research|November 11, 2009
HPV & HPV vaccination: issues in developing countriesMausumi Bharadwaj, Showket Hussain, Vilas Nasare, et al.
Molecular Biology Reports|May 14, 2011
Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian populationNisha Thakur, Showket Hussain, Vilas Nasare, et al.
Journal of Medical Virology|December 16, 2011
Human papillomavirus infection among young adolescents in India: impact of vaccinationShowket Hussain, Mausumi Bharadwaj, Vilas Nasare, et al.
Breast Cancer Research and Treatment|April 15, 2008
Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian populationIndu Kohaar, Pratibha Tiwari, Rakesh Kumar, et al.
Plos One|November 12, 2014
Perception of human papillomavirus infection, cervical cancer and HPV vaccination in North Indian populationShowket Hussain, Vilas Nasare, Malasha Kumari, et al.
Medical Oncology (Northwood, London, England)|March 27, 2024
Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive reviewSandipan Dasgupta, Sakuntala Gayen, Tania Chakraborty, et al.
Personalized Medicine|May 20, 2018
CYP2D6*4 polymorphism, tramadol treatment and its clinical impact in patients with postherpetic neuralgiaNamita Vilas Nasare, Pravin Suryakantrao Deshmukh, Basu Dev Banerjee, et al.
American Journal of Therapeutics|April 10, 2013
CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia PatientsNamita Vilas Nasare, Basu Dev Banerjee, Pravin Suryakantrao Deshmukh, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vaccine|May 6, 2008
Prospects and prejudices of human papillomavirus vaccines in IndiaBhudev C Das, Showket Hussain, Vilas Nasare, et al.
Medical Oncology (Northwood, London, England)|December 14, 2024
Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeuticsSushmita Ghosh, Arpana Sharma, R Suresh Kumar, et al.
The Indian Journal of Medical Research|November 11, 2009
HPV & HPV vaccination: issues in developing countriesMausumi Bharadwaj, Showket Hussain, Vilas Nasare, et al.
Molecular Biology Reports|May 14, 2011
Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian populationNisha Thakur, Showket Hussain, Vilas Nasare, et al.
Journal of Medical Virology|December 16, 2011
Human papillomavirus infection among young adolescents in India: impact of vaccinationShowket Hussain, Mausumi Bharadwaj, Vilas Nasare, et al.
Breast Cancer Research and Treatment|April 15, 2008
Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian populationIndu Kohaar, Pratibha Tiwari, Rakesh Kumar, et al.
Plos One|November 12, 2014
Perception of human papillomavirus infection, cervical cancer and HPV vaccination in North Indian populationShowket Hussain, Vilas Nasare, Malasha Kumari, et al.
Medical Oncology (Northwood, London, England)|March 27, 2024
Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive reviewSandipan Dasgupta, Sakuntala Gayen, Tania Chakraborty, et al.
Personalized Medicine|May 20, 2018
CYP2D6*4 polymorphism, tramadol treatment and its clinical impact in patients with postherpetic neuralgiaNamita Vilas Nasare, Pravin Suryakantrao Deshmukh, Basu Dev Banerjee, et al.
American Journal of Therapeutics|April 10, 2013
CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia PatientsNamita Vilas Nasare, Basu Dev Banerjee, Pravin Suryakantrao Deshmukh, et al.
Pageof 2